Agios Pharma (AGIO) Tops Q4 EPS by 4c

Agios Pharma (NASDAQ: AGIO) reported Q4 EPS of ($1.58), $0.04 better than the analyst estimate of ($1.62). Revenue for the quarter came in at $30 million versus the consensus estimate of $22.04 million.

For earnings history and earnings-related data on Agios Pharma (AGIO) click here.

You May Also Be Interested In

• Solstice acquiring Element Solutions in $14.5B cash and stock deal
• Volato Group reports Q2 2026 preliminary results with Vaunt growth
• S&P Global restructures Market Intelligence into two units